skip to main content
Lingue:

The 2011 Canadian Hypertension Education Program Recommendations for the Management of Hypertension: Blood Pressure Measurement, Diagnosis, Assessment of Risk, and Therapy

Rabi, Doreen M ; Daskalopoulou, Stella S ; Padwal, Raj S ; Khan, Nadia A ; Grover, Steven A ; Hackam, Daniel G ; Myers, Martin G ; Mckay, Donald W ; Quinn, Robert R ; Hemmelgarn, Brenda R ; Cloutier, Lyne ; Bolli, Peter ; Hill, Michael D ; Wilson, Thomas ; Penner, Brian ; Burgess, Ellen ; Lamarre-Cliché, Maxime ; Mclean, Donna ; Schiffrin, Ernesto L

Canadian Journal of Cardiology, 2011, Vol.27(4), pp.415-433.e2 [Rivista Peer Reviewed]

Fulltext disponibile

Citazioni Citato da
  • Titolo:
    The 2011 Canadian Hypertension Education Program Recommendations for the Management of Hypertension: Blood Pressure Measurement, Diagnosis, Assessment of Risk, and Therapy
  • Autore: Rabi, Doreen M ; Daskalopoulou, Stella S ; Padwal, Raj S ; Khan, Nadia A ; Grover, Steven A ; Hackam, Daniel G ; Myers, Martin G ; Mckay, Donald W ; Quinn, Robert R ; Hemmelgarn, Brenda R ; Cloutier, Lyne ; Bolli, Peter ; Hill, Michael D ; Wilson, Thomas ; Penner, Brian ; Burgess, Ellen ; Lamarre-Cliché, Maxime ; Mclean, Donna ; Schiffrin, Ernesto L
  • Note di contenuto: We updated the evidence-based recommendations for the diagnosis, assessment, prevention, and treatment of hypertension in adults for 2011. The major guideline changes this year are: (1) a recommendation was made for using comparative risk analogies when communicating a patient's cardiovascular risk; (2) diagnostic testing issues for renal artery stenosis were discussed; (3) recommendations were added for the management of hypertension during the acute phase of stroke; (4) people with hypertension and diabetes are now considered high risk for cardiovascular events if they have elevated urinary albumin excretion, overt kidney disease, cardiovascular disease, or the presence of other cardiovascular risk factors; (5) the combination of an angiotensin-converting enzyme (ACE) inhibitor and a dihydropyridine calcium channel blocker (CCB) is preferred over the combination of an ACE inhibitor and a thiazide diuretic in persons with diabetes and hypertension; and (6) a recommendation was...
  • Fa parte di: Canadian Journal of Cardiology, 2011, Vol.27(4), pp.415-433.e2
  • Soggetti: Medicine
  • Lingua: Inglese
  • Tipo: Articolo
  • Identificativo: ISSN: 0828-282X ; E-ISSN: 1916-7075 ; DOI: 10.1016/j.cjca.2011.03.015

Ricerca in corso nelle risorse remote ...